BREAKING NEWS: Three individuals have been charged in connection with the alleged assisted suicide of a Gold Coast man using a veterinary euthanasia drug. This urgent investigation has expanded to include multiple deaths as authorities continue to probe the circumstances surrounding the use of the drug, pentobarbitone.
The charges come after a coroner’s report revealed that the **43-year-old man** died from acute pentobarbitone toxicity in April 2023. Following an extensive investigation, police have arrested two men, aged **53 and 80**, along with an **81-year-old woman**. Detective Inspector Mark Mooney announced that the investigation, which began with one death, may involve several others dating back to **2021**.
“We believe this number could grow as the investigation continues,” stated Det Insp Mooney. Authorities are particularly concerned about a business named **End of Life Services**, urging anyone with information to come forward.
UPDATE: The **53-year-old** man from Main Beach faces serious charges, including two counts of aiding suicide and multiple counts related to drug trafficking. He is scheduled to appear at **Southport Magistrates Court** on **Thursday**. The **81-year-old woman** has also been charged with aiding suicide and will return to court on **Tuesday**. Meanwhile, the **80-year-old** man from Ashmore faces charges related to trafficking and possession, with a court date set for **September 26**.
This disturbing case highlights the vulnerability of individuals seeking end-of-life options, prompting authorities to remind the public of the strict legal safeguards in place in **Queensland**. “The alleged offender is deliberately targeting vulnerable people, taking advantage of them in their most desperate moments,” Det Insp Mooney emphasized.
Police are calling for increased awareness regarding these serious issues, underscoring the importance of legal processes designed to protect individuals considering end-of-life care.
If you or someone you know is in need of support, please contact **Lifeline** at **13 11 14** or **beyondblue** at **1300 22 4636**.
Stay tuned for further updates as this developing story unfolds.
